A.R.T. Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-11,743
| Closed | -$1.26M | – | 649 |
|
|
2019
Q4 | $1.26M | Buy |
+11,743
| New | +$1.26M | 0.06% | 460 |
|
|
2019
Q2 | – | Sell |
-8,267
| Closed | -$728K | – | 1534 |
|
|
2019
Q1 | $728K | Sell |
8,267
-3,500
| -30% | -$308K | 0.04% | 600 |
|
|
2018
Q4 | $840K | Sell |
11,767
-4,833
| -29% | -$345K | 0.05% | 503 |
|
|
2018
Q3 | $2.04M | Buy |
+16,600
| New | +$2.04M | 0.09% | 286 |
|
|
2018
Q2 | – | Sell |
-37,600
| Closed | -$3.12M | – | 1654 |
|
|
2018
Q1 | $3.12M | Sell |
37,600
-55,100
| -59% | -$4.57M | 0.13% | 234 |
|
|
2017
Q4 | $7.19M | Buy |
+92,700
| New | +$7.19M | 0.32% | 39 |
|
|
2017
Q1 | – | Sell |
-53,600
| Closed | -$2.07M | – | 1611 |
|
|
2016
Q4 | $2.07M | Buy |
53,600
+46,100
| +615% | +$1.78M | 0.12% | 253 |
|
|
2016
Q3 | $379K | Sell |
7,500
-21,673
| -74% | -$1.1M | 0.12% | 262 |
|
|
2016
Q2 | $1.33M | Buy |
+29,173
| New | +$1.33M | 0.07% | 447 |
|
|
2016
Q1 | – | Sell |
-62,105
| Closed | -$3.51M | – | 1559 |
|
|
2015
Q4 | $3.51M | Sell |
62,105
-46,100
| -43% | -$2.61M | 0.17% | 146 |
|
|
2015
Q3 | $4.31M | Buy |
108,205
+52,633
| +95% | +$2.09M | 0.16% | 166 |
|
|
2015
Q2 | $2.65M | Buy |
55,572
+3,329
| +6% | +$159K | 0.09% | 352 |
|
|
2015
Q1 | $2.07M | Buy |
+52,243
| New | +$2.07M | 0.07% | 383 |
|
|
2014
Q1 | – | Sell |
-151,584
| Closed | -$1.42M | – | 1485 |
|
|
2013
Q4 | $1.42M | Buy |
151,584
+117,440
| +344% | +$1.1M | 0.08% | 373 |
|
|
2013
Q3 | $386K | Sell |
34,144
-76,047
| -69% | -$860K | 0.02% | 874 |
|
|
2013
Q2 | $1.47M | Buy |
+110,191
| New | +$1.47M | 0.05% | 486 |
|